BCL2 and amyotrophic lateral sclerosis: Whileshowing no toxicity in ALS -patient-derived cells, 6 displayedan overall neuroprotective and neuroinflammatory profile in neuronal(CGN) and non-neuronal (N9 and lymphoblast) cells comparable to thoseof the reference compounds as well as their equimolar combination.However, no increase in the level of the Bcl-2 anti-apoptotic markerwas observed.